120 related articles for article (PubMed ID: 8319375)
1. The effects of growth hormone on protein metabolism in adult growth hormone deficient patients.
Russell-Jones DL; Weissberger AJ; Bowes SB; Kelly JM; Thomason M; Umpleby AM; Jones RH; Sönksen PH
Clin Endocrinol (Oxf); 1993 Apr; 38(4):427-31. PubMed ID: 8319375
[TBL] [Abstract][Full Text] [Related]
2. Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy.
Russell-Jones DL; Weissberger AJ; Bowes SB; Kelly JM; Thomason M; Umpleby AM; Jones RH; Sönksen PH
Acta Endocrinol (Copenh); 1993 Jun; 128 Suppl 2():44-7. PubMed ID: 8342393
[TBL] [Abstract][Full Text] [Related]
3. Whole-body leucine turnover in adults on conventional treatment for hypopituitarism.
Beshyah SA; Sharp PS; Gelding SV; Halliday D; Johnston DG
Acta Endocrinol (Copenh); 1993 Aug; 129(2):158-64. PubMed ID: 8372601
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study.
Whitehead HM; Boreham C; McIlrath EM; Sheridan B; Kennedy L; Atkinson AB; Hadden DR
Clin Endocrinol (Oxf); 1992 Jan; 36(1):45-52. PubMed ID: 1559299
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
Mauras N; Martinez V; Rini A; Guevara-Aguirre J
J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
[TBL] [Abstract][Full Text] [Related]
6. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
Mauras N
J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
[TBL] [Abstract][Full Text] [Related]
7. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.
Fowelin J; Attvall S; Lager I; Bengtsson BA
Metabolism; 1993 Nov; 42(11):1443-7. PubMed ID: 8231841
[TBL] [Abstract][Full Text] [Related]
8. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy--a clinical research center study.
Vlachopapadopoulou E; Zachwieja JJ; Gertner JM; Manzione D; Bier DM; Matthews DE; Slonim AE
J Clin Endocrinol Metab; 1995 Dec; 80(12):3715-23. PubMed ID: 8530624
[TBL] [Abstract][Full Text] [Related]
10. Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study.
Hansen TB; Vahl N; Jørgensen JO; Christiansen JS; Hagen C
Clin Endocrinol (Oxf); 1995 Dec; 43(6):689-96. PubMed ID: 8736270
[TBL] [Abstract][Full Text] [Related]
11. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
Lucidi P; Lauteri M; Laureti S; Celleno R; Santoni S; Volpi E; Angeletti G; Santeusanio F; De Feo P
J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
[TBL] [Abstract][Full Text] [Related]
12. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
13. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.
Salomon F; Cuneo RC; Hesp R; Sönksen PH
N Engl J Med; 1989 Dec; 321(26):1797-803. PubMed ID: 2687691
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone modulates amino acid oxidation in the surgical patient: leucine kinetics during the fasted and fed state using moderate nitrogenous and caloric diet and recombinant human growth hormone.
Carli F; Webster JD; Halliday D
Metabolism; 1997 Jan; 46(1):23-8. PubMed ID: 9005964
[TBL] [Abstract][Full Text] [Related]
15. Administration of recombinant human growth hormone on alternate days is sufficient to increase whole body protein synthesis and lipolysis in growth hormone deficient adults.
Lucidi P; Laureti S; Santoni S; Lauteri M; Busciantella-Ricci N; Angeletti G; Santeusanio F; De Feo P
Clin Endocrinol (Oxf); 2000 Feb; 52(2):173-9. PubMed ID: 10671944
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone decreases protein catabolism in children with cystic fibrosis.
Hardin DS; Ellis KJ; Dyson M; Rice J; McConnell R; Seilheimer DK
J Clin Endocrinol Metab; 2001 Sep; 86(9):4424-8. PubMed ID: 11549686
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults.
Russell-Jones DL; Bowes SB; Rees SE; Jackson NC; Weissberger AJ; Hovorka R; Sonksen PH; Umpleby AM
Am J Physiol; 1998 Jun; 274(6):E1050-6. PubMed ID: 9611155
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of growth hormone treatment in GH-deficient adults.
Jørgensen JO; Pedersen SA; Thuesen L; Jørgensen J; Ingemann-Hansen T; Skakkebaek NE; Christiansen JS
Lancet; 1989 Jun; 1(8649):1221-5. PubMed ID: 2566779
[TBL] [Abstract][Full Text] [Related]
19. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition.
Binnerts A; Swart GR; Wilson JH; Hoogerbrugge N; Pols HA; Birkenhager JC; Lamberts SW
Clin Endocrinol (Oxf); 1992 Jul; 37(1):79-87. PubMed ID: 1424196
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.
Mauras N; Beaufrere B
J Clin Endocrinol Metab; 1995 Mar; 80(3):869-74. PubMed ID: 7533772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
